- Home
- SVM vs AVBP Comparison
SVM vs AVBP Comparison
Compare SVM & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- AVBP
- Stock Information
- Founded
- SVM N/A
- AVBP 2021
- Country
- SVM Canada
- AVBP United States
- Employees
- SVM N/A
- AVBP N/A
- Industry
- SVM Precious Metals
- AVBP
- Sector
- SVM Basic Materials
- AVBP
- Exchange
- SVM Nasdaq
- AVBP NYSE
- Market Cap
- SVM 906.7M
- AVBP 862.8M
- IPO Year
- SVM N/A
- AVBP 2024
- Fundamental
- Price
- SVM $5.14
- AVBP $21.63
- Analyst Decision
- SVM Strong Buy
- AVBP Strong Buy
- Analyst Count
- SVM 1
- AVBP 8
- Target Price
- SVM $6.75
- AVBP $38.38
- AVG Volume (30 Days)
- SVM 6.9M
- AVBP 484.4K
- Earning Date
- SVM 08-12-2025
- AVBP 08-13-2025
- Dividend Yield
- SVM 0.49%
- AVBP N/A
- EPS Growth
- SVM 40.00
- AVBP N/A
- EPS
- SVM 0.28
- AVBP N/A
- Revenue
- SVM $298,895,000.00
- AVBP N/A
- Revenue This Year
- SVM $1.10
- AVBP $85.82
- Revenue Next Year
- SVM $26.47
- AVBP N/A
- P/E Ratio
- SVM $18.29
- AVBP N/A
- Revenue Growth
- SVM 38.90
- AVBP N/A
- 52 Week Low
- SVM $2.87
- AVBP $15.47
- 52 Week High
- SVM $5.32
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- SVM 71.35
- AVBP 47.74
- Support Level
- SVM $4.45
- AVBP $19.71
- Resistance Level
- SVM $4.94
- AVBP $22.32
- Average True Range (ATR)
- SVM 0.20
- AVBP 1.32
- MACD
- SVM 0.06
- AVBP -0.20
- Stochastic Oscillator
- SVM 99.58
- AVBP 31.89
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.